Early histological changes in the kidney of people with morbid obesity. - Wikidata - awgldk - TriplyDB

Early histological changes in the kidney of people with morbid obesity.

Early histological changes in the kidney of people with morbid obesity.

http://www.wikidata.org/entity/Q45930192

about

Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients.Mid-adulthood risk factor profiles for CKD Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors.Does a nephron deficit exacerbate the renal and cardiovascular effects of obesity?Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney Obesity Correlates With Glomerulomegaly But Is Not Associated With Kidney Dysfunction Early After Donation.Abdominal Adipose Tissue was Associated with Glomerular Hyperfiltration among Non- Diabetic and Normotensive Adults with a Normal Body Mass Index Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England.Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children.Sex Differences in Associations Among Obesity, Metabolic Abnormalities, and Chronic Kidney Disease in Japanese Men and Women.Scope and mechanisms of obesity-related renal disease.The role of obesity in kidney disease: recent findings and potential mechanisms.Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics.Novel targets of antifibrotic and anti-inflammatory treatment in CKD.Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathy.Glomerulopathy Associated With Moderate Obesity.Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy.The Renal Pathology of Obesity.Association between excess body weight and urine protein concentration in healthy dogs.Associations between body mass index and the risk of renal events in patients with type 2 diabetes.Higher body mass index is associated with higher fractional creatinine excretion in healthy subjects.Increased urine podocyte-associated messenger RNAs in severe obesity are evidence of podocyte injury.

P2860

Q28079155-62C6CC7C-7DB3-4F5F-92E4-6FCF2DD41C13 Q33813773-A484B19D-E100-416F-BC1A-85EDCD8A524D Q34427602-98F800F6-C422-43A7-B5DD-71E1466AE4AF Q34455166-8BC463DA-F752-4D51-A02D-78B51DEA3532 Q34748373-FBFA116C-C89E-43E0-982D-26C90CD0119A Q34982802-52D95058-A32A-4318-B41E-FB4759DEE371 Q35005734-EB0922F2-8CC8-4339-AC98-ED458FCCDFEA Q35026645-A652ED7E-F84D-49D6-8CF1-67A556B105FA Q35674096-5867B3B2-7A48-4818-9BE2-87B24F3FB5A2 Q35818630-BC639090-8B8A-4647-A36C-6B41738E613A Q36300946-5F772978-920A-4D51-9063-AA8A3A07DC03 Q36914364-684CCDC7-2894-41AC-8642-3D8F7512C131 Q37140664-01E6F742-F833-4564-849A-72DEA69E4F15 Q37687825-CF82FF3D-F560-41C3-A068-6664E468D85B Q37872237-242D245A-B9F1-41DE-BF01-AA8CD719F61B Q37886981-6872EB91-7BB0-44EB-B1A5-584FD0BFA173 Q38157805-7CA02512-EA3B-41DF-A86B-13BBFAD24ED2 Q38198872-DC83D051-B2B9-4041-8905-18A98FCE8DB7 Q44820167-54044B3A-00D3-42DB-89B9-465401A8BDA9 Q47106733-AD7DB800-9CA9-49E5-B4B4-5BD934370E8C Q47108672-0B526C0B-F77C-40F4-B198-B223A3C8707C Q47136838-E8C40251-1BEB-437C-9948-569A380F23F5 Q47175561-2E726355-5510-43D5-972A-746BD461C468 Q47674377-68119B4F-A379-40C3-A5DA-2D8EFD700A6F Q51497127-45BB6B35-73BC-45FC-AD04-3C83250AB1E2 Q53439401-04E1F30B-DE90-45F1-BB3A-E89C6AC0499E

P2860

Early histological changes in the kidney of people with morbid obesity.

http://www.wikidata.org/entity/Q45930192

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Early histological changes in the kidney of people with morbid obesity.

@en

Early histological changes in the kidney of people with morbid obesity.

@nl

type

label

Early histological changes in the kidney of people with morbid obesity.

@en

Early histological changes in the kidney of people with morbid obesity.

@nl

prefLabel

Early histological changes in the kidney of people with morbid obesity.

@en

Early histological changes in the kidney of people with morbid obesity.

@nl

P1433

Q45930192-79D317FD-94F4-4A94-8A00-D581BE953FF6

P1476

Q45930192-2482F0E6-72CA-4988-8179-16D038BDC532

P2093

Q45930192-1B56C7A2-E725-418A-8C09-9A61E55BF9E7

Q45930192-2F9E0879-3371-4EB6-A0C8-3731A55C0A87

Q45930192-5A420394-C337-4A52-BA25-C33FA05D636C

Q45930192-91DE4741-1341-4682-915A-9342989260A4

Q45930192-AAEA590D-E690-4CBC-8175-8037BF6821A9

Q45930192-AEA07CE5-BF19-40A3-817A-33CE088E7BA5

Q45930192-DB506E11-72E2-4C78-84AF-8CE092ACFE20

Q45930192-F498A35F-C54B-4E99-8760-C3BDCD3035F4

P2860

Q45930192-0A24C362-AB67-454F-8E58-084DF240C980

Q45930192-3295A6A4-60EB-4ED8-A65B-457133A2412F

Q45930192-65E64CB9-EB6F-4D2F-BBE0-80823A5B9A5F

Q45930192-73478DC1-E858-494C-9235-13F381345CFB

Q45930192-84DA1348-397C-4406-9280-C3FC4B6F8B70

Q45930192-9684FA74-7BA2-4AC3-91D7-4C0F038B36D6

Q45930192-9C2CD8C9-4A0D-4B99-9657-A0EF59CC3294

Q45930192-A23FD292-CA5E-485B-8D3F-2226BF710611

Q45930192-B6B1006E-EEE3-4DBE-9265-749CB517E55E

Q45930192-B939BFD2-2495-469C-8205-A61792511C74

P304

Q45930192-3A4C1A8A-CCA3-4585-9FB8-08E6D532DCC2

P31

Q45930192-CF84847B-382F-46DD-B21E-D51580802A99

P356

Q45930192-9ABAF64E-E8C5-4612-9CC2-6B24BDF2EACE

P407

Q45930192-9E63B565-1840-4018-A102-C60D2D8E5284

P433

Q45930192-E60E52BF-88A8-4239-8687-C97CA72B503C

P478

Q45930192-F6BC1629-0486-416C-809D-DFC2E4B65E2A

P50

Q45930192-22F5E675-BE09-496A-872A-FA013F7CDA89

P577

Q45930192-93AE11E0-A63E-475B-B944-C658705E095D

P5875

Q45930192-71AF4872-B548-48FD-A7C2-F990663EE791

P698

Q45930192-6BCEF719-D215-4A39-82D0-478F85E52582

P921

Q45930192-CA06A063-A736-4643-BD26-6B18FCBAA9B6

P356

P1433

Nephrology Dialysis Transplantation

P1476

Early histological changes in the kidney of people with morbid obesity.

@en

P2093

Bart Wagner

http://www.w3.org/2001/XMLSchema#string

Bisher Kawar

http://www.w3.org/2001/XMLSchema#string

Charalambos Spyropoulos

http://www.w3.org/2001/XMLSchema#string

Dimitrios S Goumenos

http://www.w3.org/2001/XMLSchema#string

Fotios Kalfarentzos

http://www.w3.org/2001/XMLSchema#string

John G Vlachojannis

http://www.w3.org/2001/XMLSchema#string

Meguid El Nahas

http://www.w3.org/2001/XMLSchema#string

Sara Conti

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and Trends in Obesity Among US Adults, 1999-2000

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Prevalence of overweight and obesity in the United States, 1999-2004

Obesity-related glomerulopathy: an emerging epidemic.

Obesity and renal disease.

Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.

Overview: obesity: what does it have to do with kidney disease?

Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

P304

3732-3738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFP329

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26665443

http://www.w3.org/2001/XMLSchema#string

P698

19596742

http://www.w3.org/2001/XMLSchema#string

P921